CN Patent

CN112190583B — 一种乐伐替尼药物组合物及其制备方法

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2021-10-29 · 5y expired

What this patent protects

本发明提供了一种新的乐伐替尼药物组合物及其制备方法，该药物组合物含有乐伐替尼或其药学上可接受的盐和抗酸抗胆汁胃粘膜保护剂，其中，保护剂为铝碳酸镁。该药物组合物既能充分保证产品的溶出，也避免药物降解，更好地确保产品的质量。

USPTO Abstract

本发明提供了一种新的乐伐替尼药物组合物及其制备方法，该药物组合物含有乐伐替尼或其药学上可接受的盐和抗酸抗胆汁胃粘膜保护剂，其中，保护剂为铝碳酸镁。该药物组合物既能充分保证产品的溶出，也避免药物降解，更好地确保产品的质量。

Drugs covered by this patent

Patent Metadata

Patent number
CN112190583B
Jurisdiction
CN
Classification
—
Expires
2021-10-29
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Easton Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.